Rhinovirus: Clinical Trials

4 trials for Rhinovirus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4

Follow Rhinovirus: new trials by email Literature Review of Rhinovirus trials Research Report on Rhinovirus

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
Vapendavir, Placebo - COPD Exacerbation Acute, COPD With Acute Lower Respiratory Infection
Phase 2CompletedAltesa Biosciences, Inc.522023-11-202025-09-30
Effect of OC459 on the Response to Rhinovirus Challenge in Asthma
OC459, Placebo, Rhinovirus - Asthma, Rhinovirus
Phase 2CompletedImperial College London442015-01-012021-02-26
A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
BTA798, Placebo - Rhinovirus
Phase 2CompletedBiota Scientific Management Pty Ltd3002010-08-012018-05-31
Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure (Study P04295)
Pleconaril, Placebo to Pleconaril - Asthma, Common Cold
Phase 2CompletedMerck Sharp & Dohme LLC3112006-08-012015-07-16

Narrower conditions

Common Cold (3)  ·  Asthma (2)  ·  Picornaviridae Infections (2)  ·  Emphysema (1)  ·  Enterovirus Infections (1)  ·  Eosinophilia (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Obstructive (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  RNA Virus Infections (1)  ·  Respiration Disorders (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Virus Diseases (1)

Broader conditions

Bronchial Diseases (2)  ·  Hypersensitivity (2)  ·  Hypersensitivity, Immediate (2)  ·  Immune System Diseases (2)  ·  Infections (2)  ·  Lung Diseases (2)  ·  Lung Diseases, Obstructive (2)  ·  RNA Virus Infections (2)  ·  Respiratory Hypersensitivity (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Virus Diseases (2)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Hematologic Diseases (1)

Interventions

(5-fluoro-2-methyl-3-quinolin-2-ylmethylindo-1-yl)acetic acid (1)  ·  Glucose (1)  ·  pleconaril (1)

Sponsors

Altesa Biosciences, Inc. (1)  ·  Biota Scientific Management Pty Ltd (1)  ·  Imperial College London (1)  ·  Merck Sharp & Dohme LLC (1)

Countries

United Kingdom (2)  ·  United States (1)

Top investigators

John Lambert, PhD (1)  ·  Onn Min Kon, MD (1)  ·  Sebastian L Johnston, MBBS PhD (1)